|
|
Scientific Program
|
 |
|
|
THE EMBRYO |
Friday, 30 March 2012 | |
|
09:00-10:15
Chairperson: |
SESSION 1: NEW ERA OF MORPHOLOGICAL BIOMARKERS
David Gardner, Australia |
|
09:00-09:15 |
Course Introduction and Orientation by Meeting Co-Chairperons
Denny Sakkas, USA; Carlos Simón, Spain |
|
09:15-09:45 |
Clinical relevance of morphokinetics to assess embryo viability
Marcos Meseguer, Spain |
|
09:45-10:15 |
Correlated time lapse imaging and molecular analysis to assess embryo viability
Sheshua Shen, USA |
| |
|
|
10:15-11:15
Chairperson: |
SESSION 2: GENETIC-BASED BIOMARKERS
Alan Handyside, UK |
|
10:15-10:45 |
Use of Comparative Genomic Hybridization (CGH) for embryo assessment. Clinical results
Carmen Rubio, Spain |
|
10:45-11:15
|
Four hour 24 chromosome aneuploidy screening and class I evidence of safety, predictive value, and clinical efficacy
Nathan Treff, USA |
| |
|
|
11:15-11:45 |
Coffee Break |
| |
|
|
11:45-13:15
Chairperson: |
SESSION 2 (continued): GENETIC-BASED BIOMARKERS
Alan Handyside, UK |
|
11:45-12:15 |
Emerging role for SNP-based technologies for preimplantation genetic screening
Alan Handyside, UK |
|
12:15-12:45 |
New PGD techniques based on massive sequencing
Julio Martín, Spain |
|
12:45-13:15 |
Cumulus cells as markers of oocyte and embryo quality
Emre Seli, USA |
| |
|
|
13:15-13:30 |
Technical Break |
| |
|
|
13:30-14:15 |
LUNCH SYMPOSIUM SPONSORED BY MERCK SERONO
GRANT FOR FERTILITY INNOVATION: DEVELOPING INNOVATIVE TECHNOLOGIES TO BECOME BEST IN CLASS IN TAKE HOME BABY RATE
Rapid inexpensive DNA fragmentation analysis of sperm & cumulus cells
Dagan Wells, UK |
|
|
|
14:15-14:30 |
Technical Break |
| |
|
|
14:30-16:00
Chairperson: |
SESSION 3: NON-INVASIVE BIOMARKERS
Denny Sakkas, USA |
|
14:30-15:00 |
Non invasive metabolomic profiling of embryos using spectroscopy
Denny Sakkas, USA |
|
15:00-15:30 |
Glucose to assess embryo viability and sex
David Gardner, Australia |
|
15:30-16:00
|
Non invasive biomarkers to discriminate embryo aneuploidy
Francisco Domínguez, Spain |
| |
|
|
16:00-16:30 |
Coffee Break |
| |
|
|
16:30-17:30
Chairperson: |
SESSION 4: NEW TECHNOLOGIES “IN PROGRESS”
Lois Salamonsen, Australia |
|
16:30-17:00 |
Embryology in the era of proteomics
Mandy Katz-Jaffe, USA |
|
17:00-17:30 |
Fetal DNA in maternal blood
Brynn Levy, USA (Natera, Inc.) | |
|
THE OVARIAN RESERVE, SPERM AND THE ENDOMETRIUM |
Saturday, 31 March 2012 | |
|
09:00-11:00
Chairperson: |
SESSION 5: THE OVARIAN RESERVE AND GAMETES
Nick Macklon, UK |
|
09:00-09:30 |
Biomarkers of ovarian response
Scott Nelson, UK |
|
09:30-10:00 |
Polymorphisms as biomarkers of ovarian reserve and oocyte quality
Maria Lalioti, USA |
|
|
Novel technologies for selecting the best sperm for IVF and ICSI
Denny Sakkas, USA |
|
10:30-11:00 |
Assessment of sperm using microarray technology
Nicolas Garrido, Spain |
| |
|
|
|
|
| |
|
|
11:30-13:30
Chairperson: |
SESSION 6: THE ENDOMETRIUM
Carlos Simón, Spain |
|
11:30-12:00 |
Profiling the gene signature of endometrial receptivity. Clinical results
Carlos Simón, Spain |
|
|
Proteomics of the human endometrium
Lois Salamonsen, Australia |
|
12:30-13:00 |
Secretomics of the endometrium
Nick Macklon, UK |
|
13:00-13:30 |
Q & A |
| |
|
|
13:30-13:45 |
Technical Break |
| |
|
| 13:45-14:30 |
LUNCH SYMPOSIUM SPONSORED BY MERCK SERONO
GRANT FOR FERTILITY INNOVATION: DEVELOPING INNOVATIVE TECHNOLOGIES TO BECOME BEST IN CLASS IN TAKE HOME BABY RATE
Lipidomics: A non-invasive diagnostic method of human endometrial receptivity
Carlos Simón, Spain |
| |
|
|
14:30-15:00 |
Coffee Break |
|
|
|
15:00-17:00
Chairpersons: |
SESSION 7: CLINICAL TRANSLATION: THE TRANSLATORS. WHAT COMPANIES ARE IN THE HORIZON? (Part 1)
Denny Sakkas, USA; Carlos Simón, Spain |
|
15:00-15:15 |
Morphokinetic embryo analysis – “The Vision to Conceive”
Niels Birger Ramsing, Denmark (Unisense FertiliTech A/S) |
|
15:15-15:30 |
Getting started with 24sure PGS aneuploidy screening
Graham Snudden, UK (BlueGnome Ltd.) |
| 15:30-15:45 |
How to Incorporate NIPD into practice
Solomon Moshkevich, USA (Natera, Inc.) |
| 15:45-16:00 |
A services provider of genetic diagnosis
David Jimenez, Spain (Iviomics, S.L.) |
|
Chairpersons:
|
SESSION 7: CLINICAL TRANSLATION: THE TRANSLATORS. WHAT COMPANIES ARE IN THE HORIZON? (Part 2)
Denny Sakkas, USA; Carlos Simón, Spain |
|
16:00-16:40 |
How will new technologies be introduced and what will be their potential commercial impact?
Diego Ezcurra, USA |
| 16:40-17:00 |
General Discussion |
| Chairpersons: |
David Gardner, Australia; Carlos Simón, Spain |
|
| |
|
|
|
|
|
WebStudio.co.il
